133 related articles for article (PubMed ID: 6966966)
1. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
Plunkett W; Chubb S; Alexander L; Montgomery JA
Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
[No Abstract] [Full Text] [Related]
2. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
Dow LW; Bell DE; Poulakos L; Fridland A
Cancer Res; 1980 May; 40(5):1405-10. PubMed ID: 6245791
[No Abstract] [Full Text] [Related]
3. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
White EL; Shaddix SC; Brockman RW; Bennett LL
Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
[TBL] [Abstract][Full Text] [Related]
4. Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.
Plunkett W; Alexander L; Chubb S; Loo TL
Cancer Res; 1979 Sep; 39(9):3655-60. PubMed ID: 476690
[No Abstract] [Full Text] [Related]
5. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
6. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
[TBL] [Abstract][Full Text] [Related]
7. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
Müller WE; Maidhof A; Zahn RK; Shannon WM
Cancer Res; 1977 Jul; 37(7 Pt 1):2282-90. PubMed ID: 301056
[No Abstract] [Full Text] [Related]
8. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
Huang P; Plunkett W
Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.
Lipper RA; Machkovech SM; Drach JC; Higuchi WI
Mol Pharmacol; 1978 Mar; 14(2):366-9. PubMed ID: 642934
[No Abstract] [Full Text] [Related]
10. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
Kufe DW; Major PP; Munroe D; Egan M; Herrick D
Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
Lee SH; Caron N; Kimball AP
Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.
Hidaka T; Katayama K; Yamashita K; Yamashita T; Watanabe K; Shimazaki M; Ohno M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Mar; 33(3):303-9. PubMed ID: 7380742
[TBL] [Abstract][Full Text] [Related]
13. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
Helland S; Ueland PM
Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
[TBL] [Abstract][Full Text] [Related]
14. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
Struck RF; Shortnacy AT; Kirk MC; Thorpe MC; Brockman RW; Hill DL; El Dareer SM; Montgomery JA
Biochem Pharmacol; 1982 Jun; 31(11):1975-8. PubMed ID: 7115418
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
Shewach DS; Plunkett W
Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210.
Caron N; Lee SH; Kimball AP
Cancer Res; 1977 Sep; 37(9):3274-9. PubMed ID: 884674
[TBL] [Abstract][Full Text] [Related]
18. Cellular retention of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and the pattern of recovery of DNA synthesis in Chinese hamster ovary cells.
Shewach DS; Plunkett W
Cancer Res; 1986 Apr; 46(4 Pt 1):1581-4. PubMed ID: 2418951
[TBL] [Abstract][Full Text] [Related]
19. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
Lee SH; Thomas LK; Unger FM; Christian R; Sartorelli AC
Int J Cancer; 1981 May; 27(5):703-8. PubMed ID: 6974703
[No Abstract] [Full Text] [Related]
20. Metabolism and toxicity of 9-beta-D-arabinofuranosyladenine in human malignant T cells and B cells in tissue culture.
Carson DA; Kaye J; Seegmiller JE
Adv Exp Med Biol; 1979; 122B():299-307. PubMed ID: 317567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
